<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T12:33:55Z</responseDate>
  <request identifier="oai:figshare.com:article/34036718" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34036718</identifier>
        <datestamp>2026-09-30T19:19:42Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Fluorinated Aliphatic
Thiols in the Design of Cephalosporin
Conjugates for Metallo-β-Lactamase Inhibition</dc:title>
          <dc:creator>Alexandra Kondratieva (25145939)</dc:creator>
          <dc:creator>Philip Rainsford (11510092)</dc:creator>
          <dc:creator>Perwez Bakht (20356711)</dc:creator>
          <dc:creator>Ranjana Pathania (384841)</dc:creator>
          <dc:creator>Annette Bayer (1696084)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>thus incompletely resolved</dc:subject>
          <dc:subject>serious clinical threat</dc:subject>
          <dc:subject>leaving group properties</dc:subject>
          <dc:subject>leaving group ability</dc:subject>
          <dc:subject>designed compounds consist</dc:subject>
          <dc:subject>fluorinated aliphatic thiols</dc:subject>
          <dc:subject>aliphatic thiols compared</dc:subject>
          <dc:subject>cephalosporin core linked</dc:subject>
          <dc:subject>trifluoromethylated aliphatic thiol</dc:subject>
          <dc:subject>19 &lt;/ sup</dc:subject>
          <dc:subject>new delhi metallo</dc:subject>
          <dc:subject>based mbl inhibitors</dc:subject>
          <dc:subject>aliphatic thiol</dc:subject>
          <dc:subject>cephalosporin conjugates</dc:subject>
          <dc:subject>based inhibitors</dc:subject>
          <dc:subject>aromatic thiol</dc:subject>
          <dc:subject>unsolved challenges</dc:subject>
          <dc:subject>selective release</dc:subject>
          <dc:subject>rapid spread</dc:subject>
          <dc:subject>producing bacteria</dc:subject>
          <dc:subject>nonfluorinated control</dc:subject>
          <dc:subject>mediated hydrolysis</dc:subject>
          <dc:subject>hydrolysis monitoring</dc:subject>
          <dc:subject>fluorination improves</dc:subject>
          <dc:subject>findings highlight</dc:subject>
          <dc:subject>f nmr</dc:subject>
          <dc:subject>conjugate containing</dc:subject>
          <dc:subject>catalytic activity</dc:subject>
          <dc:subject>alternative method</dc:subject>
          <dc:description>Antibiotic resistance is a major global health challenge,
with
the rapid spread of metallo-β-lactamase (MBL)-expressing bacteria
presenting a serious clinical threat. In this study, we synthesized
and investigated a series of novel cephalosporin conjugates envisioned
to release MBL inhibitors upon MBL-mediated hydrolysis. The designed
compounds consist of a cephalosporin core linked to trifluoromethylated
aliphatic thiol-based MBL inhibitors. Conjugates releasing aliphatic
thiols upon hydrolysis by the New Delhi Metallo-β-lactamase-1
(NDM-1) were identified, confirming that fluorination improves the
leaving group properties of some aliphatic thiols compared to a nonfluorinated
control. However, when comparing with a conjugate containing an aromatic
thiol, fluorinated aliphatic thiol release appeared slower and mechanistically
more complex, thus incompletely resolved. The conjugates exhibited
potent inhibitory activity against several subclass B1 MBLs. In addition,
the utility of &lt;sup&gt;19&lt;/sup&gt;F NMR as an alternative method for hydrolysis
monitoring was exemplified. The findings highlight the potential,
but also some unsolved challenges, of altering the leaving group ability
of aliphatic thiol-based inhibitors to exploit the catalytic activity
of NDM-1 for the selective release of inhibitors in MBL-producing
bacteria.</dc:description>
          <dc:date>2026-09-30T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acsomega.6c07917.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Fluorinated_Aliphatic_Thiols_in_the_Design_of_Cephalosporin_Conjugates_for_Metallo-_-Lactamase_Inhibition/34036718</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
